Dr. Gundawar Ravi

Associate Professor

Date of Joining: 26.10.2021

Department of Pharmaceutical Quality Assurance

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

Dr. Gundawar Ravi is an Associate Professor in the Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences.

Responsibilities:

Teaches BPharm, and M. Pharm courses

Research Guide for PhD and M. Pharm students

Member of Research Committee & Regulatory Compliance Committee

SUBJECTS CURRENTLY TEACHING

Subject	Semester / Year
Pharmaceutical Analysis Theory	BPharm Semester I
Pharmaceutical Analysis Practical-I	BPharm Semester I
Pharmaceutical Quality Assurance	BPharm Semester VII
Quality Management Systems	MPharm Semester I
Quality Control and Quality Assurance	MPharm Semester I
Pharmaceutical Quality Assurance Practical –I	MPharm Semester I
Audit and Regulatory Compliance	MPharm Semester II
Pharmaceutical Manufacturing Technology	MPharm Semester II
Pharmaceutical Quality Assurance Practical –I	MPharm Semester II

ACADEMIC QUALIFICATIONS

Degree	Specialisation	Institute	Year of passing
Bachelore in Pharmacy	B. Pharm	JSS College of Pharmacy, Mysuru, Karnataka.	2011
Master in Pharmacy	Pharmaceutical Quality Assurance	JSS College of Pharmacy, Mysuru	2014
Ph.D.	Pharmaceutical Sciences	JSS College of Pharmacy, Mysuru	2018

Experience

Institution / Organisation	Designation	Role	Tenure
NSRT Pvt. Ltd. KASEZ, Gandhidham. (R&D Center-Rusan Pharma Ltd.)	Research Associate	Researcher	Nov - 2017 to Apr- 2019
MNR College of Pharmacy, Telangana	Associate Professor	Teaching and Research	May - 2019 to Oct - 2021

Recent innovations in microfabrication techniques for enhanced microfluidic chip performance in drug development

2025 Roy A Vasantharaju S Muddukrishna B Eranti B Pawar S.D Ravi G

https://researcher.manipal.edu/en/persons/gundawar-ravi/

Innovare Academics Sciences Pvt. Ltd 10.22159/ijap.2025v17i4.54228

Strategic approaches for selecting regulatory pathways in drug-device combination products: A comprehensive review

2025 Kumar K.A Bose P.S.C Sathyanarayana M.B Vasantharaju S.G Ligade V Amatha S Osmani R.A Barwa R. Pawar S.D Ravi G

Open Science Publishers LLP Inc. 10.7324/JAPS.2025.244706

Transdermal drug delivery system: A comprehensive review of innovative strategies, applications, and regulatory perspectives

2025 Crasta A Painginkar T Sreedevi A Pawar S.D Badamane Sathyanarayana M Vasantharaju S.G Osmani R.A.M., Ravi G.

Elsevier Inc. 10.1016/j.onano.2025.100245

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Quality Assurance, Regulatory Affairs, Formulation Research & Development

Area of Expertise

Nanotechnology, Quality by Design (QbD), Transdermal Drug Delivery System, Novel Drug Delivery System, Pharmaceutical Quality Systems

Area of Research

Nanotechnology-Based Drug Delivery Systems Targeted and Precision Medicine Approaches Advanced Therapeutic Strategies for Cancer and Infectious Diseases Drug–Device Combination Products & Regulatory Science Long-Acting Injectable Depot Formulations

Professional Affiliations & Contributions

Evaluated Poster presentation Session & Participated as Co-Ordinator and Oral Presentation Evaluator for the Conference during PERCEPT-2020, A National Seminar on Pharmaceutical Education & Research Challenges for Emerging Prospects & Trends at University College of Technology, Osmania University, Hyderabad held on 13^th & 14^th March 2020.
Worked as an Organizing Secretary for Youth Red Cross Society (YRC, 2019-20), India from MNR College of Pharmacy, Sangareddy.
Evaluated Oral presentation Session during 4^th International conference on innovations in pharmaceutical sciences (ICIPS) at Guru Nanak Institutions, Hyderabad held on 9-10^th August, 2019.
Participated as Accommodation Volunteer at the 67^th Indian pharmaceutical congress to be held at Mysuru from 19-21^st December 2015.

1. Aluri Nandini, Ravi G*. Process validation of sucralfate oral suspension. Int. J. Res. Pharm. Sci. 2021;12(3):2005-2013.

2. R. Nagaraju, U. Rajeswari, G. Ravi, P. Subhash Chandra Bose, Damineni Saritha. Development and in vitro Characterization of Intranasal Microemulsions of Sumatriptan Succinate for brain Targeting. Research J. Pharm. Tech. 2021;14(4):2062-2068.

3. G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, P. Srikanth Reddy, Sandeep Kanna. Development and Evaluation of oral controlled release tablets of oxybutynin using various polymers. Research J. Pharm. Tech. 2020;13(8):3854-3860.

4. Asra Farooqi, Damineni Saritha, K. Anupama, P. Subhash Chandra Bose, G. Ravi. Formulation and in-vitro evaluation of Dasatinib bilayered tablets. Int. J. Creative Res. Thoughts. 2020;8(6):1208-1222.

5. R. Nagaraju, P. Subhash Chandra Bose, G. Ravi, Damineni Saritha, Valluru Ravi. A Review on Current status of Buccal drug delivery system. Research J. Pharm. Tech. 2020;13(6):2954-2962.

6. S. Sivaprasad, P. Subhash Chandra Bose, Ch. Sadakvali, G. Ravi, V. Swathi. Formulation and characterization of saquinavir nanoparticles prepared by nanoprecipitation method. World J Pharm Res. 2020;9(5):2227-40.

7. G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, Sandeep Kanna. Design, Development and Evaluation of Isosorbide Mononitrate Orally Disintegrating Tablets. Int J Pharma Res Health Sci. 2020;8(2):3136-38.

8. Poreddy Srikanth Reddy, V. Alagarsamy, P. Subhash Chandra Bose, Damineni Sarita, Vuppula Sruthi, G. Ravi. Formulation and Evaluation of Zaltoprofen Immediate Release Tablets using Superdisintegrants. Research J. Pharm. Tech. 2020;13(3):1152-56.

9. M. Nagaraju and G. Ravi. Formulation and in vitro evaluation of glipizide floating beads by using various polymers. World J Pharm Res. 2020;9(4):1479-91.

10. U. Kruthika, M. Sudhasree, J. Mounika, N. Tandava Krishna, M. Divya, A. Rajani, G. Ravi. Clinical pharmacist-led program on medication reconciliation and patient counseling in the department of Gastroenterology. Int J Pharm Pharm Sci. 2020;12(1):6-10.

11. G. Ravi, N. Vishal Guptal, Valluru Ravi, P. Subhash Chandra Bose, Damineni Sarita. A Quality by Design concept on polymer-based nanoparticles containing Anti-Alzheimer’s drug. J. Global Trends Pharm Sci. 2019;10(2):6181 – 95.

12. G. Ravi, Valluru Ravi, P. Subhash Chandra Bose, Damineni Saritha. Microsponges – A comprehensive review: Success and challenges. Indo American J Pharm Res. 2019;9(7):3056-67.

13. G. Ravi, N. Vishal Gupta. In vivo study of polymeric nanoparticles loaded transdermal film for the treatment of Alzheimer’s disease. Int. J. Pharm. Sci. Rev. Res. 2019;57(2):112-15.

14. R. Nagaraju, Damineni Saritha, P. Subhash Chandra Bose, G. Ravi, Valluru Ravi. A review on current status of self-emulsifying drug delivery systems. Int J Med Biomed Studies. 2019;3(7):232-48.

15. CH. Krishna Vamsi, A. Sushmitha, P. Supriya, A. Rajani, G. Ravi. Polypharmacy in hospitalized geriatric patients in a tertiary care hospital – A Prospective study. Int J Med Biomed Studies. 2019;3(10):63-67.

16. V. Spandana, B. Sindhuja, A. Rajani, G. Ravi. Gout-an Update. European J Biomedi Pharm Sci. 2019;6(12):219-22.

17. G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita. Preparation, characterization and evaluation of Celecoxib loaded nanosponges for the treatment of Psoriatic arthritis. Int J Med Biomed Studies. 2019;3(12):181-85.

18. S Vennela, U Padma Latha, D Swathi, T Soundarya, CH Alekhya, A Rajani, G Ravi. A Prospective Study of Morbidity Pattern among Pregnant Women Attending at Tertiary Care Hospital. International Journal of Pharma Research and Health Sciences. 2019;7(6):3095-100.

19. P Srikanth Reddy, P Subhash Chandra Bose, G Ravi, V Sruthi, Damineni Saritha. Phytochemical and Pharmacological Activities of Gynura lycopersicifolis and Gnaphalium polycaulon. International Journal of Pharma Research and Health Sciences. 2019;7(6):3068-73.

20. Ravi G, Vishal Gupta N, Balamuralidhara V. Rivastigmine Tartrate Solid Lipid Nanoparticles Loaded Transdermal Film: An In vivo study. Res. J. Pharm. Tech. 2018;11(1):227-30.

21. G. Ravi, N. Vishal Gupta. Development of Solid lipid Nanoparticles of Rivastigmine Tartrate by using full factorial design for the treatment of Alzheimer’s disease. J. Pharm. Sci. Res. 2017;9(12):2447-52.

22. G. Ravi, N. Vishal Gupta, Gowrav MP. Development and evaluation of matrix diffusion controlled transdermal patches of Donepezil. J Pharm Sci. Res. 2017;11(6):686-92.

23. G. Ravi, N. Vishal Gupta, M. P. Gowrav. Microneedles - An archetype swing in transdermal drug delivery: A comprehensive review. Indo Am J Phar Res. 2017;7(1):7399-416.

24. G. Ravi, N. Vishal Gupta. Development and evaluation of transdermal film containing solid lipid nanoparticles of Rivastigmine tartrate. Int J App Pharm. 2017;9(6):85-90.

25. Ravi KSN, Gowrav MP, Gangadharappa HV, G Ravi. Management of Out of Specification (OOS) for Finished Product. Int J Pharm Clin Res. 2017;9(3):221-32.

26. Nataraj H.M, N. Vishal Gupta, G. Ravi. Validation of water purification system. Asian J. Pharm. Clin. Res. 2017;10(4):409-16.

27. Rahul Raj. S, N. Vishal Gupta, G. Ravi. Evaluation of process capability in manufacture of Anti-hypertensive tablets 10 mg. Asian J. Pharm. Clin. Res. 2017;10(4):477-82.

28. Nataraj H.M, N. Vishal Gupta, G. Ravi. Cleaning validation of cefalexin capsule. Int J Chem Tech Res. 2017;10(6):1083-95.

29. G. Ravi, N. Vishal Gupta, Gowrav MP. A review on recent trends and various preparation techniques of Polymeric nanoparticles. J. Chem. Pharm. Res. 2016;8(12):207-14.

30. G. Ravi, N. Vishal Gupta. The treatment of Alzheimer’s disease by using donepezil loaded transdermal patch. J. Chem. Pharm. Res. 2015;7(3):806-13.

31. G. Ravi, N. Vishal Gupta, Raghunandan HV., Shashikanth D. FDA Guidelines-For Out of Specifications (OOS) in Industries. Int. J. Pharm Tech Res. 2013;5(3):943-48.

Program

News

Event

Other